MedTrace Logo

Genetic Influences of Albuterol Response In Children With Bronchiolitis

NCT00570297 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 54

Last updated 2023-11-30

No results posted yet for this study

Summary

Bronchiolitis is a significant cause of morbidity and hospitalization in children, accounting for approximately 125,000 hospitalizations per year in the U.S. Recently, genetic variations of the β2-adrenergic receptor (β2-AR) have been shown to influence response to β2-AR agonist therapy in children with asthma. We suspect that genetic variations of the β2-AR also affect response to β2-AR agonist therapy in children with bronchiolitis.

Conditions

  • Bronchiolitis

Sponsors & Collaborators

  • UConn Health

    collaborator OTHER

  • Connecticut Children's Medical Center

    lead OTHER

Principal Investigators

  • Christopher L Carroll, MD · Connecticut Children's Medical Center

Eligibility

Max Age
2 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-12-31
Primary Completion
2018-04-30
Completion
2018-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00570297 on ClinicalTrials.gov